A/Prof Nicholas Clemons
Honorary (Principal Fellow)
The Sir Peter MacCallum Department of Oncology
107 Scholarly works
10 Projects
HIGHLIGHTS
2026
Journal article
Diagnostic and predictive utility of peritoneal tumor DNA in gastroesophageal cancer: A prospective multicenter study.
DOI: 10.1200/jco.2026.44.16_suppl.41012026
Journal article
Peritoneal tumour DNA—A promising peritoneal-specific biomarker for diagnosis, prognosis, and monitoring treatment response
DOI: 10.1002/ijc.703342026
Journal article
Abstract 601: Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma.
DOI: 10.1158/1538-7445.am2026-6012026
Journal article
Outcomes and Molecular Correlates of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases
DOI: 10.1097/DCR.00000000000043792023
Research grants (ARC, NHMRC, MRFF)
Improving Therapeutic Responses in Oesophageal Cancer by Overcoming Resistance to Ferroptosis
2020
Research Grant
Establishing the Functional Genetic Drivers of Oesophageal Adenocarcinoma
2017
Research Grant
A New Paradigm for Targeting Mutant P53 Tumours
RECENT SCHOLARLY WORKS
2026
Journal article
The role of gastric cancer patient-derived organoids in precision medicine: Clinicians’ perspective
DOI: 10.1016/j.stemcr.2026.1030062025
Journal article
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
DOI: 10.1038/s42003-025-08251-02025
Journal article
Role of Neoadjuvant Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer: A Systematic Review of Currently Available Studies
DOI: 10.1097/DCR.00000000000039272025
Journal article
091. MULTI-OMICS EVALUATION OF PERITONEAL FLUID IN GASTROESOPHAGEAL CANCER: RESULTS FROM INTERIM ANALYSIS
DOI: 10.1093/dote/doaf061.0062025
Journal article
Neoadjuvant intraperitoneal chemotherapy in high-risk and cytology positive gastric cancer: a systematic review
DOI: 10.1016/j.suronc.2025.1022372025
Journal article
Circulating tumor DNA (ctDNA) analysis for improved treatment response assessment and prediction of clinical outcomes in patients with esophageal cancer.
DOI: 10.1200/jco.2025.43.16_suppl.4077
RECENT PROJECTS
2023
Research grants (ARC, NHMRC, MRFF)
Gene Modified Pluripotent Stem Cells to Generate and Empower Innate Immune Cells Against Poor\2010prognosis Cancers
2024
Research grants (other domestic)
Finding and Understanding the Optimal Treatment for Gastroesophageal Cancers